Virtus ETF Advisers LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$290,000
+57.6%
10,536
-5.6%
0.12%
+52.6%
Q1 2021$184,000
-8.9%
11,160
+1.8%
0.08%
-7.1%
Q4 2020$202,000
-27.9%
10,959
-46.8%
0.08%
-42.9%
Q3 2020$280,000
-33.2%
20,599
-12.0%
0.15%
-25.8%
Q2 2020$419,000
+1.0%
23,395
-43.8%
0.20%
+15.8%
Q1 2020$415,000
+7.0%
41,612
-12.7%
0.17%
+171.4%
Q4 2019$388,00047,6850.06%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders